当前位置: 首页 > 期刊 > 《中国美容医学》 > 2011年第7期 > 正文
编号:12121253
直视下处理注射隆乳并发症同期假体隆乳体会(1)
http://www.100md.com 2011年7月1日 曾海波 王新灿
第1页

    参见附件(1991KB,3页)。

     [摘要]目的:探讨经直视下处理聚丙烯酰胺水凝胶注射隆乳术后并发症并同期行假体隆乳的适应证。方法:通过对接受注射者症状、体征归纳总结,分别行MRI检查,并采用手术直视下取出加残腔灌洗以及病变组织去除术等综合治疗手段,分析63例聚丙烯酰胺水凝胶注射隆乳术后并发症的处理方法以及同期置入假体的适应证。结果:本组63例治疗效果基本满意。MRI复查显示无明显的聚丙烯酰胺水凝胶残留,其中41例同期置入假体,效果良好。结论:聚丙烯酰胺水凝胶注射隆乳术对受术者可造成后严重后果;MRI是目前最好的检查方法;手术直视下取出加残腔灌洗以及病变组织去除术是目前治疗并发症的最好方式;严格把握同期置入假体的适应证。

    [关键词]聚丙烯酰胺水凝胶;并发症;隆乳术

    [中图分类号]R655.8[文献标识码]A[文章编号]1008-6455(2011)07-1063-03

    Treatment of the complications of polyacrylamide hydrogel injection for augmentation mammaplasty

    ZENG Hai-bo1,WANG Xin-can2

    (1.Department of Cosmetic Surgery,Shanghai Sheng'ai Hospital,Shanghai 201821,China; 2. Guangzhou Sogood Cosmetology Hospital)

    Abstract:ObjectiveTo find the best method to deal with the postoperative complications of augmentation mammaplasty by injecting polyacrylamide hydrogel and the indication of implanting at the same time.MethodsMRI and pathologic examinations were made to 63 patients with the serious postoperative complications of augmentation mammaplasty by injecting polyacrylamide hydrogel. Then,on visualized removed the polyacrylamide hydrogel,the pathologic tissue and irrigation of the cavity by operation.The clinical data were analyzed and the experience in the treatment of the complications was summarized.ResultsAll patients were satisfied with the result of the operation. MRI examination showed that no visible polyacrylamide hydrogel remained in the cavity. 41 cases were implanted prosthesis and the result was well.ConclusionPolyacrylamide hydrogel injection for augmentation mammaplasty could do serious result to woman. MRI was the best examination against it. The best therapy for the complications of polyacrylamide hydrogel injection was orphotic removing of the polyacrylamide hydrogel and the pathologic tissue and irrigation of the cavity.

    Key words:polyacrylamide hydrogel; complication; augmentation mammaplasty

    聚丙烯酰胺水凝胶(Polyacrylamide Hydrogel,PAAG)作为一种医用软组织填充材料,自1997 年引入我国以来,曾广泛应用于注射隆乳。2007年6月~2009年6月,笔者对63例曾行聚丙烯酰胺水凝胶注射隆乳后出现并发症来就诊的患者根据其具体并发症的情况采用乳晕切口手术直视下取出加残腔灌洗以及病变组织去除术等综合治疗手段,术后疗效基本满意,其中41例Ⅰ期同期置入假体,效果良好。

    1资料和方法

    1.1 临床资料:本组共63例,其中32例未曾生育哺乳,31例为哺乳后乳房萎缩,年龄24~48岁,平均年龄29.7岁。注射水凝胶隆乳术后并发症出现时间为13个月至7年。注射物的商品名是从乌克兰引入的“interfall”及中国生产的“奥美定” ......

您现在查看是摘要介绍页,详见PDF附件(1991KB,3页)